Familial amyloidosis echocardiography and ultrasound

Jump to: navigation, search

Familial amyloidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Familial amyloidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Familial amyloidosis echocardiography and ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Familial amyloidosis echocardiography and ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Familial amyloidosis echocardiography and ultrasound

CDC on Familial amyloidosis echocardiography and ultrasound

Familial amyloidosis echocardiography and ultrasound in the news

Blogs on Familial amyloidosis echocardiography and ultrasound

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Familial amyloidosis echocardiography and ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Echocardiography may be helpful in the diagnosis of familial amyloidosis. Findings on an echocardiography suggestive of familial amyloidosis include sparkling or speckled appearance of the left ventricular thickening, hypertrophied right ventricle, diastolic dysfunction with restrictive filling pattern (in the advanced stages), severe atrial dilatation, thickening of the interatrial septum, pericardial effusion, and prominent valves.

Echocardiography/Ultrasound

Echocardiography

References

  1. Klein AL, Hatle LK, Burstow DJ, Seward JB, Kyle RA, Bailey KR, Luscher TF, Gertz MA, Tajik AJ (April 1989). "Doppler characterization of left ventricular diastolic function in cardiac amyloidosis". J. Am. Coll. Cardiol. 13 (5): 1017–26. PMID 2647814.
  2. Pantazis A, Vischer AS, Perez-Tome MC, Castelletti S (March 2015). "Diagnosis and management of hypertrophic cardiomyopathy". Echo Res Pract. 2 (1): R45–53. doi:10.1530/ERP-15-0007. PMC 4676455. PMID 26693331.
  3. Eshaghian S, Kaul S, Shah PK (2007). "Cardiac amyloidosis: new insights into diagnosis and management". Rev Cardiovasc Med. 8 (4): 189–99. PMID 18192942.

Linked-in.jpg